Platelet Function Testing In Clinical Practice: Are We Ready For Prime Time?

被引：7

作者：

Angiolillo, Dominick J. ^{[1
]}

机构：

[1] Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL 33209 USA

来源：

REVISTA ESPANOLA DE CARDIOLOGIA | 2009年 / 62卷 / 02期

关键词：

PERCUTANEOUS CORONARY INTERVENTION; ELUTING STENT IMPLANTATION; DUAL ANTIPLATELET THERAPY; OF-CARE ASSAY; DIABETES-MELLITUS; ARTERY-DISEASE; CLOPIDOGREL RESPONSIVENESS; CARDIOVASCULAR OUTCOMES; REACTIVITY; RESISTANCE;

D O I：

10.1016/S0300-8932(09)70151-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：113 / 116

页数：4

共 20 条

[11] Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: A multicenter randomized prospective study [J].

Bonello, Laurent ;

Camoin-Jau, Laurence ;

Arques, Stephane ;

Boyer, Christian ;

Panagides, Dimitri ;

Wittenberg, Olivier ;

Simeoni, Marie-Claude ;

Barragan, Paul ;

Dignat-George, Francoise ;

Paganelli, Franck .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (14) :1404-1411

[12] Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention [J].

Buch, Ashesh N. ;

Singh, Suman ;

Roy, Probal ;

Javaid, Aamir ;

Smith, Kimberly A. ;

George, Christopher E. ;

Pichard, Augusto D. ;

Satler, Lowell F. ;

Kent, Kenneth M. ;

Suddath, William O. ;

Waksman, Ron .

AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (11) :1518-1522

[13] Relation of low response to Clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris [J].

Cuisset, Thomas ;

Hamilos, Michalis ;

Sarma, Jaydeep ;

Sarno, Giovanna ;

Wyffels, Eric ;

Vanderheyden, Marc ;

Barbato, Emanuele ;

Bartunek, Jozef ;

De Bruyne, Bernard ;

Wijns, William .

AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (12) :1700-1703

[14] Post-Treatment Platelet Reactivity Predicts Long-Term Adverse Events Better Than the Response to Clopidogrel in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome [J].

de Miguel Castro, Antonio ;

Cuellas Ramon, Carlos ;

Diego Nieto, Alejandro ;

Samaniego Lampon, Beatriz ;

Alonso Rodriguez, David ;

Fernandez Vazquez, Felipe ;

Alonso Orcajo, Norberto ;

Carbonell de Blas, Raul ;

Pascual Vicente, Cristina ;

Perez de Prado, Armando .

REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62 (02) :126-135

[15] Drug-eluting stenting followed by cilostazol treatment reduces late Restenosis in patients with diabetes mellitus - The DECLARE-DIABETES trial (a randomized comparison of triple antiplatelet therapy with dual antiplatelet therapy after drug-eluting stent implantation in diabetic patients) [J].

Lee, Seung-Whan ;

Park, Seong-Wook ;

Kim, Young-Hak ;

Yuri, Sung-Cheol ;

Park, Duk-Woo ;

Lee, CheolWhan ;

Hong, Myeong-Ki ;

Kim, Hyun-Sook ;

Ko, Jae-Ki ;

Park, Jae-Hyeong ;

Lee, Jae-Hwan ;

Choi, S. Wan ;

Seong, In-Whan ;

Cho, Yoon Haeng ;

Lee, Nae-Hee ;

Kim, June Hong ;

Chun, Kook-Jin ;

Park, Seung-Jung .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (12) :1181-1187

[16] Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention - Results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) Study [J].

Patti, Giuseppe ;

Nusca, Annunziata ;

Mangiacapra, Fabio ;

Gatto, Laura ;

D'Ambrosio, Andrea ;

Di Sciascio, Germano .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (14) :1128-1133

[17] Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation [J].

Price, Matthew J. ;

Endemann, Sarah ;

Gollapudi, Raghava R. ;

Valencia, Rafael ;

Stinis, Curtiss T. ;

Levisay, Justin P. ;

Ernst, Alissa ;

Sawhney, Neil S. ;

Schatz, Richard A. ;

Teirstein, Paul S. .

EUROPEAN HEART JOURNAL, 2008, 29 (08) :992-1000

[18] Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R).: Rationale for the study and protocol design [J].

Valgimigli, Marco ;

Campo, Gianluca ;

de Cesare, Nicoletta ;

Vranckx, Pascal ;

Hamon, Martial ;

Angiolillo, Dominick J. ;

Sabate, Manel ;

Ferrari, Fabrizio ;

Furgieri, Alessandro ;

Tumscitz, Carlo ;

Repetto, Alessandra ;

Colangelo, Salvatore ;

Meliga, Emanuele ;

Kubbajeh, Moh'd ;

Parrinello, Giovanni ;

Percoco, Gianfranco ;

Ferrari, Roberto .

CARDIOVASCULAR DRUGS AND THERAPY, 2008, 22 (04) :313-320

[19] Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention - The prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial [J].

Wiviott, Stephen D. ;

Trenk, Dietmar ;

Frelinger, Andrew L. ;

O'Donoghue, Michelle ;

Neumann, Franz-Josef ;

Michelson, Alan D. ;

Angiolillo, Dominick J. ;

Hod, Hanoch ;

Montalescot, Gilles ;

Miller, Debra L. ;

Jakubowski, Joseph A. ;

Cairns, Richard ;

Murphy, Sabina A. ;

McCabe, Carolyn H. ;

Antman, Elliott M. ;

Braunwald, Eugene .

CIRCULATION, 2007, 116 (25) :2923-2932

[20] Prasugrel versus clopidogrel in patients with acute coronary syndromes [J].

Wiviott, Stephen D. ;

Braunwald, Eugene ;

McCabe, Carolyn H. ;

Montalescot, Gilles ;

Ruzyllo, Witold ;

Gottlieb, Shmuel ;

Neumann, Franz-Joseph ;

Ardissino, Diego ;

De Servi, Stefano ;

Murphy, Sabina A. ;

Riesmeyer, Jeffrey ;

Weerakkody, Govinda ;

Gibson, C. Michael ;

Antman, Elliott M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20) :2001-2015

← 1 2 →